NYRADA INC. (ASX:NYR)
Who is NYRADA INC. (ASX:NYR)?
Nyrada Inc (ASX:NYR) is a US registered, Australia domiciled clinical-stage biotechnology company developing Transient Receptor Potential Canonical (TRPC) ion channel inhibitors to treat a range of medical conditions.
Industry & Specialities
Pharmaceuticals
Manufacturing
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2018 (8 years)
Address:
180 GEORGE ST; LEVEL 22/23, SALESFORCE TOWER; SYDNEY, NEW SOUTH WALES 2000, AU
Employees by Department
- The Rest (5)
- Total (5)
Key Decision Makers
Benjamin Evison
Chief Scientific Officer
Jasneet Parmar
Director, Research and Development
Phillip Coghlan
Director, Medicinal and Pharmaceutical Chemistry
James Bonnar
Managing Director & CEO
Employees by Seniority
C-level
2employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NYRADA INC. (ASX:NYR) been operating for?
- What is the funding status of NYRADA INC. (ASX:NYR)?
- Where is NYRADA INC. (ASX:NYR)'s headquarter?
- What NYRADA INC. (ASX:NYR)'s spending power?
- Does NYRADA INC. (ASX:NYR) have a presence in the domain it operates in?